Pharmacokinetics of low-dose methotrexate in rheumatoid arthritis patients.
暂无分享,去创建一个
D. Furst | J. Hoffman | P. Veng‐Pedersen | R. A. Herman | R. Koehnke | J. Hoffman | Raechelle K. Koehnke
[1] P. Veng‐Pedersen,et al. Single pass mean residence time in peripheral tissues: a distribution parameter intrinsic to the tissue affinity of a drug. , 1986, Journal of pharmaceutical sciences.
[2] J. Kremer,et al. The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis. , 1986, Arthritis and rheumatism.
[3] M. Guttadauria,et al. Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial. , 1985, Arthritis and rheumatism.
[4] M. Weinblatt,et al. Efficacy of low-dose methotrexate in rheumatoid arthritis. , 1985, The New England journal of medicine.
[5] R. Kauffman,et al. High-performance liquid chromatographic assay for methotrexate utilizing a cold acetonitrile purification and separation of plasma or cerebrospinal fluid. , 1985, Journal of chromatography.
[6] F. Jamali,et al. Low‐dose methotrexate kinetics in arthritis , 1984, Clinical pharmacology and therapeutics.
[7] R. Lippens. Methotrexate. I. Pharmacology and pharmacokinetics. , 1984, The American journal of pediatric hematology/oncology.
[8] T. Taylor,et al. Low dose oral methotrexate in rheumatoid arthritis: an uncontrolled trial and review of the literature. , 1983, Seminars in arthritis and rheumatism.
[9] Willkens Rf,et al. Methotrexate: a perspective of its use in the treatment of rheumatic diseases. , 1982 .
[10] W. Bleyer. The clinical pharmacology of methotrexate. new applications of an old drug , 1978, Cancer.
[11] S. Rosenberg,et al. Use of plasma pharmacokinetics to predict and prevent methotrexate toxicity. , 1977, The New England journal of medicine.
[12] P. Engstrom,et al. Comparison of serum concentrations of methotrexate after various routes of administration , 1975, Cancer.
[13] B. Hoogstraten,et al. Effect of route of administration and effusions on methotrexate pharmacokinetics. , 1974, Cancer research.
[14] B. Hoogstraten,et al. Pharmacokinetics of methotrexate , 1973, Clinical pharmacology and therapeutics.
[15] E. Henderson,et al. The metabolic fate of tritiated methotrexate. II. Absorption and excretion in man. , 1965, Cancer research.